QGEN QGEN

Qiagen NV Stock Price

47.85
0.65 (1.38%)
Upgrade to Real-Time
Afterhours (Closed)
47.85
Volume 1,352,559
Bid Price
Ask Price
News -
Day High 47.88

Low
41.32

52 Week Range

High
58.00

Day Low 46.67
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Qiagen NV QGEN NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
0.65 1.38% 47.85 18:00:00
Open Price Low Price High Price Close Price Prev Close
46.72 46.67 47.88 47.85 47.20
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
13,575 1,352,559 $ 47.22 $ 63,863,191 - 41.32 - 58.00
Last Trade Time Type Quantity Stock Price Currency
19:00:00 53,930 $ 47.85 USD

Period:

Draw Mode:

Qiagen NV Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 10.88B 227.45M 195.59M $ 2.25B $ 538.82M 2.21 20.10
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - -

more financials information »

Qiagen NV News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical QGEN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week46.1447.8845.7746.861,159,0661.713.71%
1 Month46.0447.8842.4445.27957,7901.813.93%
3 Months48.8149.2442.4445.59841,169-0.96-1.97%
6 Months55.1255.1241.3247.12810,745-7.27-13.19%
1 Year48.5058.0041.3250.11795,936-0.65-1.34%
3 Years40.8759.0024.8043.141,238,6456.9817.08%
5 Years32.0659.0024.8041.421,134,78915.7949.25%

Qiagen NV Description

Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (45% of 2021 sales), followed by EMEA (36%) and Asia-Pacific (19%).


Your Recent History
NYSE
QGEN
Qiagen NV
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.